Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

SSP buys Australia's ARE for undisclosed sum

(Sharecast News) - Travel food outlet operator SSP Group on Monday said it had bought Airport Retail Enterprises in Australia for an undisclosed sum. Founded in 1971, privately-owned ARE is a food and beverage operator, with annualised sales in the region of AUD $200m (£100m) from 62 outlets, principally bars, casual dining restaurants and cafes, across seven Australian airports.

SSP said the acquisition was part of its plan to accelerate growth in the Asia Pacific region and will see the group enhance its presence in Australia.

From 2023 to 2030, international passenger air traffic in Australia is expected to grow by an average of 10% a year, with domestic passenger numbers expected to grow by an annual average of 3-4%.

The acquisition is expected to complete by the end of June, subject to necessary approvals including regulatory clearance and client consents.

Reporting by Frank Prenesti for Sharecast.com

Share this article

Related Sharecast Articles

Yellow Cake NAV slips as uranium values decline
(Sharecast News) - Uranium investor Yellow Cake reported a rise in uranium holdings but a decrease in net asset value due to lower spot prices in its interim results on Tuesday.
Digitalbox FY EBITDA now seen ahead of internal expectations
(Sharecast News) - Digital media business Digtalbox said on Tuesday that it now expects FY24 revenues to be at least £3.5m, while underlying earnings were also seen ahead of management's expectations.
Dianomi expects to record small loss in FY24
(Sharecast News) - Digital advertising business Dianomi warned on Tuesday that it and to record a small loss in FY24 compared to market expectations of a small profit.
Ixico secures new contract with US-based client
(Sharecast News) - Neuroscience imaging firm Ixico has signed a contract with a new US-based client to provide imaging services for a Phase 2 Huntington's Disease clinical trial.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.